← Back to Search

Device

Epidural Stimulation for Spinal Cord Injury (HEMO Trial)

N/A
Waitlist Available
Led By Aaron Phillips, PhD
Research Sponsored by Aaron Phillips
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and during the testing phase, an average of 9 months
Awards & highlights

HEMO Trial Summary

This trial is testing a new way to stimulate the spinal cord to help people with chronic injuries to the cervical or high-thoracic area of the spine. The goal is to improve their hemodynamic stability and quality of life.

Eligible Conditions
  • Spinal Cord Injury

HEMO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and during the testing phase, an average of 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and during the testing phase, an average of 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Occurrence of Adverse Events and Serious Adverse Events that are deemed related or possibly related to the study procedure or to the study investigational system, from implant surgery until the end of study
Secondary outcome measures
Dysautonomia
Daily stimulation log
Echocardiogram (Ejection Fraction)
+7 more

HEMO Trial Design

1Treatment groups
Experimental Treatment
Group I: Targeted Epidural Spinal StimulationExperimental Treatment1 Intervention
Participants will undergo surgery to implant devices that will be used for Targeted Epidural Spinal Stimulation (TESS).

Find a Location

Who is running the clinical trial?

Aaron PhillipsLead Sponsor
Aaron Phillips, PhDPrincipal InvestigatorUniversity of Calgary

Media Library

Targeted Epidural Spinal Stimulation (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05044923 — N/A
Spinal Cord Injury Research Study Groups: Targeted Epidural Spinal Stimulation
Spinal Cord Injury Clinical Trial 2023: Targeted Epidural Spinal Stimulation Highlights & Side Effects. Trial Name: NCT05044923 — N/A
Targeted Epidural Spinal Stimulation (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05044923 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment figure for this research project?

"Correct. Data hosted on clinicaltrials.gov verifies that this research study, which was originally posted on December 1st 2021, is actively looking for volunteers. Approximately 8 individuals are needed to be enrolled from a single location."

Answered by AI

Is the research team still looking for participants to join this trial?

"Clinicaltrials.gov reveals that this medical trial is currently recruiting, having been initially posted on December 1st 2021 and most recently updated on the 20th of the same month."

Answered by AI

Do I meet the qualifications for participation in this experiment?

"Prospective participants for this clinical trial must have suffered from a spinal cord injury and should not exceed the age of 70. A total of 8 patients are needed to complete the study."

Answered by AI

Are individuals over the age of sixty being included in this research?

"Eligibility for this trial is limited to participants aged 18 - 70. However, there are separate clinical trials available specifically for those below the age of majority and another 732 studies that cater towards individuals 65 years or older."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of Calgary
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
~2 spots leftby Apr 2025